name:-0.06696081161499
name:-0.022829055786133
name:-0.015691995620728
ZHENG; Pan Patent Filings

ZHENG; Pan

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZHENG; Pan.The latest application filed is for "cd80 and cd86 binding protein compositions and uses thereof".

Company Profile
14.24.57
  • ZHENG; Pan - Potomac MD
  • ZHENG; Pan - Washington DC
  • Zheng; Pan - Baltimore MD
  • Zheng; Pan - Ann Arbor MI
  • Zheng; Pan - Columbus OH
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
CD80 and CD86 Binding Protein Compositions and Uses Thereof
App 20220259286 - LIU; Yang ;   et al.
2022-08-18
CD80 and CD86 Binding Protein Compositions and Uses Thereof
App 20220259285 - LIU; Yang ;   et al.
2022-08-18
Methods Of Use Of Soluble Cd24 For Treating Systemic Lupus Erythematosus
App 20220125874 - LIU; Yang ;   et al.
2022-04-28
Methods of Use of Soluble CD24 for Neuroprotection and Remyelination
App 20220098278 - Liu; Yang ;   et al.
2022-03-31
CD80 and CD86 binding protein compositions and uses thereof
Grant 11,261,233 - Liu , et al. March 1, 2
2022-03-01
Targeting CD24-Siglec Interactions for Treating Subjects with Prediabetes or Diabetes
App 20220000974 - Liu; Yang ;   et al.
2022-01-06
Targeting CD24-Siglec Interactions for the Treatment and Prevention of Nonalcoholic Steatohepatitis
App 20220000973 - Liu; Yang ;   et al.
2022-01-06
Echinomycin formulation, method of making and method of use thereof
Grant 11,116,726 - Liu , et al. September 14, 2
2021-09-14
Methods Of Use Of Cd24 For The Prevention And Treatment Of Leukemia Relapse
App 20210268061 - Liu; Yang ;   et al.
2021-09-02
Methods Of Use Of Cd24 For The Prevention And Treatment Of Graft Versus Host Disease And Mucositis
App 20210228680 - Liu; Yang ;   et al.
2021-07-29
Anti-cd24 Compositions And Uses Thereof
App 20210214458 - Liu; Yang ;   et al.
2021-07-15
Use of CD24 for lowering low-density lipoprotein cholesterol levels
Grant 11,026,995 - Liu , et al. June 8, 2
2021-06-08
Uses Of Hypoxia-inducible Factor Inhibitors
App 20210161991 - LIU; Yang ;   et al.
2021-06-03
Use of CD24 Proteins for Treating Leptin-Deficient Conditions
App 20210162006 - LIU; Yang ;   et al.
2021-06-03
Methods Of Selecting And Designing Safer And More Effective Anti-ctla-4 Antibodies For Cancer Therapy
App 20210047410 - Liu; Yang ;   et al.
2021-02-18
Mutant Anti-ctla-4 Antibodies With Improved Immunotherapeutic Effect But Attenuated Adverse Effects
App 20210040212 - Liu; Yang ;   et al.
2021-02-11
Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis
App 20200399345 - Zheng; Xincheng ;   et al.
2020-12-24
Use of CD24 proteins for treating leptin-deficient conditions
Grant 10,799,558 - Liu , et al. October 13, 2
2020-10-13
Methods of use of soluble CD24 for therapy of rheumatoid arthritis
Grant 10,793,617 - Zheng , et al. October 6, 2
2020-10-06
Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and Uses Thereof
App 20200283526 - LIU; Yang ;   et al.
2020-09-10
Methods Of Use Of Soluble Cd24 For Treating Immune Related Adverse Events In Cancer Therapies
App 20200197485 - LIU; Yang ;   et al.
2020-06-25
Methods Of Use Of Soluble Cd24 For Neuroprotection And Remyelination
App 20200181235 - LIU; Yang ;   et al.
2020-06-11
Compositions Comprising Aptamers And Nucleic Acid Payloads And Methods Of Using The Same
App 20200171068 - Liu; Yang ;   et al.
2020-06-04
Uses Of Hypoxia-inducible Factor Inhibitors
App 20200147167 - LIU; Yang ;   et al.
2020-05-14
Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof
Grant 10,618,960 - Liu , et al.
2020-04-14
Use Of Cd24 For Lowering Low-density Lipoprotein Cholesterol Levels
App 20190307841 - LIU; Yang ;   et al.
2019-10-10
CD80 and CD86 Binding Protein Compositions and Uses Thereof
App 20190263889 - LIU; Yang ;   et al.
2019-08-29
Uses Of Hypoxia-inducible Factor Inhibitors
App 20190255140 - Liu; Yang ;   et al.
2019-08-22
Use of CD24 for lowering low-density lipoprotein cholesterol levels
Grant 10,369,197 - Liu , et al.
2019-08-06
Chimeric and Humanized Anti-Human CTLA4 Monoclonal Antibodies and Uses Thereof
App 20190127468 - LIU; Yang ;   et al.
2019-05-02
Immunotherapeutics For Cancer And Autoimmune Diseases
App 20190119353 - BAI; Xue-Feng ;   et al.
2019-04-25
Use of CD24 Proteins for Treating Leptin-Deficient Conditions
App 20190038716 - LIU; Yang ;   et al.
2019-02-07
Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis
App 20190016783 - Zheng; Xincheng ;   et al.
2019-01-17
Echinomycin Formulation, Method of Making and Method of Use Thereof
App 20180344642 - LIU; Yang ;   et al.
2018-12-06
Uses Of Hypoxia-inducible Factor Inhibitors
App 20180177841 - Liu; Yang ;   et al.
2018-06-28
Use Of Cd24 For Lowering Low-density Lipoprotein Cholesterol Levels
App 20180110828 - LIU; Yang ;   et al.
2018-04-26
Uses of hypoxia-inducible factor inhibitors
Grant 9,877,998 - Liu , et al. January 30, 2
2018-01-30
Uses Of Hypoxia-inducible Factor Inhibitors
App 20170239315 - Liu; Yang ;   et al.
2017-08-24
Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis
App 20170233453 - Zheng; Xincheng ;   et al.
2017-08-17
Uses of hypoxia-inducible factor inhibitors
Grant 9,623,070 - Liu , et al. April 18, 2
2017-04-18
Methods of use of soluble CD24 for therapy of rheumatoid arthritis
Grant 9,611,309 - Zheng , et al. April 4, 2
2017-04-04
Uses Of Hypoxia-inducible Factor Inhibitors
App 20170035832 - Liu; Yang ;   et al.
2017-02-09
Uses of hypoxia-inducible factor inhibitors
Grant 9,427,413 - Liu , et al. August 30, 2
2016-08-30
Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis
App 20150239953 - Zheng; Xincheng ;   et al.
2015-08-27
Methods of use of soluble CD24 for therapy of rheumatoid arthritis
Grant 8,895,022 - Zheng , et al. November 25, 2
2014-11-25
Methods of use of soluble CD24 for therapy of rheumatoid arthritis
Grant 8,808,697 - Zheng , et al. August 19, 2
2014-08-19
Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis
App 20140107322 - Zheng; Xincheng ;   et al.
2014-04-17
Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis
Grant 8,637,013 - Liu , et al. January 28, 2
2014-01-28
Methods Of Blocking Tissue Destruction By Autoreactive T Cells
App 20130296249 - Liu; Yang ;   et al.
2013-11-07
Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis
App 20130231464 - Zheng; Xincheng ;   et al.
2013-09-05
Methods Of Use Of Soluble Cd24 For Therapy Of Rheumatoid Arthritis
App 20130136739 - Zheng; Xincheng ;   et al.
2013-05-30
Methods Of Blocking Tissue Destruction By Autoreactive T Cells
App 20120294884 - Liu; Yang ;   et al.
2012-11-22
Uses Of Hypoxia-inducible Factor Inhibitors
App 20120264697 - Liu; Yang ;   et al.
2012-10-18
Treatment Of Drug-related Side Effect And Tissue Damage By Targeting The Cd-24-hmgb1-siglec10 Axis
App 20120201819 - LIU; Yang ;   et al.
2012-08-09
Treatment of drug-related side effect and tissue damage by targeting the CD24-HMGB1-Siglec10 axis
Grant 8,163,281 - Liu , et al. April 24, 2
2012-04-24
Materials and methods for FOXP3 tumor suppression
Grant 8,158,596 - Liu , et al. April 17, 2
2012-04-17
Treatment Of Drug-related Side Effect And Tissue Damage By Targeting The Cd24-hmgb1-siglec10 Axis
App 20110064746 - Liu; Yang ;   et al.
2011-03-17
Method of treating multiple sclerosis and related t-cell initiated tissue destruction by administering HSA/CD24
Grant 7,744,894 - Liu , et al. June 29, 2
2010-06-29
Materials And Methods For FOXP3 Tumor Suppression
App 20090325868 - Liu; Yang ;   et al.
2009-12-31
Human Monoclonal Anti-ctla4 Antibodies In Cancer Treatment
App 20090252741 - Liu; Yang ;   et al.
2009-10-08
Animal model for identifying agents that inhibit or enhance CTLA4 signaling
Grant 7,504,554 - Liu , et al. March 17, 2
2009-03-17
Polymorphic Cd24 Genotypes that are Predictive of Multiple Sclerosis Risk and Progression
App 20090011407 - Liu; Yang ;   et al.
2009-01-08
Combination Therapy With Anti-Ctla4 and Anti-4-1BB Antibodies
App 20080152655 - Liu; Yang ;   et al.
2008-06-26
Animal Model For Identifying Agents That Inhibit Or Enhance Ctla4 Signaling
App 20070283452 - Liu; Yang ;   et al.
2007-12-06
Animal model for identifying agents that inhibit or enhance CTLA4 signaling
Grant 7,161,058 - Liu , et al. January 9, 2
2007-01-09
Methods of blocking tissue destruction by autoreactive T cells
App 20050214290 - Liu, Yang ;   et al.
2005-09-29
Methods of blocking tissue destruction by autoreactive T cells
App 20050202014 - Liu, Yang ;   et al.
2005-09-15
Methods of blocking tissue destruction by autoreactive T cells
App 20050204413 - Liu, Yang ;   et al.
2005-09-15
Methods of blocking tissue destruction by autoreactive T cells
App 20050204415 - Liu, Yang ;   et al.
2005-09-15
Methods of blocking tissue destruction by autoreactive T cells
App 20050204414 - Liu, Yang ;   et al.
2005-09-15
Animal model for identifying agents that inhibit or enhance CTLA4 signaling
App 20050172351 - Liu, Yang ;   et al.
2005-08-04
Animal model for identifying agents that inhibit or enhance CTLA4 signaling
Grant 6,875,904 - Liu , et al. April 5, 2
2005-04-05
Methods of blocking tissue destruction by autoreactive T cells
App 20030106084 - Liu, Yang ;   et al.
2003-06-05
Method of blocking tissue destruction by autoreactive T cells
App 20030095966 - Liu, Yang ;   et al.
2003-05-22
Animal model for identifying agents that inhibit or enhance CTLA4 signaling
App 20020115209 - Liu, Yang ;   et al.
2002-08-22
Company Registrations
NCAGE Code4A1K2ZHENG, PAN
CAGE Code4A1K2ZHENG, PAN
S.A.M. Registration4A1K2 [618958305]ZHENG, PAN

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed